Evidence map›Paper›PMID 27581074›Full record

ArticleInfectious diseases of poverty2016

Epidemiological and clinical aspects of urogenital schistosomiasis in women, in Burkina Faso, West Africa.

Adama Zida, Janika Briegel, Ibrahim Kabré, Marcel P Sawadogo, Ibrahim Sangaré, Sanata Bamba, Abdourahamane Yacouba, Amado Ouédraogo, Dieudonné Yonli, François Drabo and 4 more

Open access · goldAbstract read
In one paragraph

Article in Infectious diseases of poverty, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Prevalence and Molecular Identification ofTropical medicine and infectious disease · 2022
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Adama ZidaService de Parasitologie-Mycologie, Centre Hospitalier Universitaire Yalgado Ouédraogo, 03 BP 7022, Ouaga, 03, Burkina Faso. zidaadama@live.fr.
Janika BriegelService de Parasitologie-Mycologie, Centre Hospitalier Universitaire Yalgado Ouédraogo, 03 BP 7022, Ouaga, 03, Burkina Faso.
Ibrahim KabréService de Parasitologie-Mycologie, Centre Hospitalier Universitaire Yalgado Ouédraogo, 03 BP 7022, Ouaga, 03, Burkina Faso.
Marcel P SawadogoService de Parasitologie-Mycologie, Centre Hospitalier Universitaire Yalgado Ouédraogo, 03 BP 7022, Ouaga, 03, Burkina Faso.
Ibrahim SangaréInstitut Supérieur des Sciences de la Santé, Université Polytechnique de Bobo-Dioulasso, Bobo-Dioulasso, Burkina Faso.
Sanata BambaInstitut Supérieur des Sciences de la Santé, Université Polytechnique de Bobo-Dioulasso, Bobo-Dioulasso, Burkina Faso.
Abdourahamane YacoubaEcole Privée de Santé Sciences Nouvelles/Centre Médical des Sciences Nouvelles, Ouagadougou, Burkina Faso.
Amado OuédraogoMinistère de la Santé, Direction de la Lutte contre la Maladie, Ouagadougou, Burkina Faso.
Dieudonné YonliEcole Privée de Santé Sciences Nouvelles/Centre Médical des Sciences Nouvelles, Ouagadougou, Burkina Faso.
François DraboMinistère de la Santé, Direction de la Lutte contre la Maladie, Ouagadougou, Burkina Faso.
Lady Kady TraoréUnité de Formation et de Recherche en Sciences de la Santé, Université de Ouagadougou, Ouagadougou, Burkina Faso.
Ramata Ouédraogo-TraoréUnité de Formation et de Recherche en Sciences de la Santé, Université de Ouagadougou, Ouagadougou, Burkina Faso.
Robert Tinga GuiguemdéUnité de Formation et de Recherche en Sciences de la Santé, Université de Ouagadougou, Ouagadougou, Burkina Faso.
Jürgen WackerDepartment of Obstetrics and Gynecology Bruchsal, Heidelberg University Hospital, Heidelberg, Germany.
Centre Hospitalier Universitaire Yalgado Ouédraogo · BFUniversité Joseph Ki-Zerbo · BFHeidelberg University · DEMinistère De La Santé · BFNazi Boni University · BF

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBecause infections with Schistosoma Haematobium usually peak in childhood, the majority of studies on schistosomiasis have focused on school-aged children. This study aimed to assess the epidemiological and clinical aspects of urogenital schistosomiasis in women in Burkina Faso, West Africa.

methodsA cross-sectional study was conducted in a mesoendemic region (Kombissiri) and a hyperendemic region (Dori) for schistosomiasis in Burkina Faso. A total of 287 females aged 5 to 50 years were included in the study. S. haematobium infection was assessed using the urine filtration method and dipsticks were used for the detection of hematuria. Interviews were conducted to identify clinical aspects and risk factors related to urogenital schistosomiasis.

resultsThe overall prevalence of S. haematobium infection in Dori was 21.3 %, where as Kombissiri was less affected with a prevalence of 4.6 %. The most affected age group was the 10- to 14-year-olds (41.2 %), followed by the 15- to 19-year-olds (26.3 %). Risk factors significantly associated with schistosomiasis (P <0.05) were place of residence, age, contact with open water in the past year, and distance of home to open water. The percentage of participants who had contact with open water was significantly higher among the women living in Dori compared to Kombissiri. Females over 15 years of age showed a significant higher rate of water contact compared to the 5- to 15-year-olds. A significant correlation between schistosomiasis and hematuria was established. Microhematuria showed a sensitivity of 80.6 %, a specificity of 92.7 %, and a positive predictive value of 61.7 %, whereas macrohematuria had a sensitivity of 47.2 %, a specificity of 99.2 %, and a positive predictive value of 89.5 %. The mass distribution of praziquantel in Burkina Faso is well established. However, over half of the participants with schistosomiasis in this study said they took praziquantel in the past 6 months, which indicates a high reinfection rate. This may be associated with a lack of knowledge about the transmission of schistosomiasis. Only 6 % of the participants in Kombissiri and 1.5 % in Dori knew about the correct mode of transmission.

conclusionsThe results of our study indicate that distribution campaigns should be extended from school-aged children to young women. Our data also demonstrate the necessity of combining already established mass distribution campaigns with information campaigns, so that long-term elimination, or at least reduction, of schistosomiasis can be achieved.

Indexed as

AdolescentAdultAge FactorsAnimalsBurkina FasoChildChild, PreschoolCross-Sectional StudiesFemaleHealth Knowledge, Attitudes, PracticeHumansMiddle AgedMorbidityPraziquantelPrevalenceRisk FactorsPraziquantelSchistosomicidesBurkina FasoClinicEpidemiologyUrogenital schistosomiasisWomen

Identifiers

PMID27581074
PMCPMC5007686
OpenAlexW2490894445

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.